RECENT ADVANCES IN THE DISCOVERY OF CYCLIN-DEPENDENT KINASE 2 (CDK2) SELECTIVE INHIBITORS

ADVERTISEMENT RETURN TO BOOKPREVChapterNEXTRECENT ADVANCES IN THE DISCOVERY OF CYCLIN-DEPENDENT KINASE 2 (CDK2) SELECTIVE INHIBITORSKevin D. Freeman-CookKevin D. Freeman-CookPlexium, San Diego, California, U.S.A.More by Kevin D. Freeman-Cook and Robert L. HoffmanRobert L. HoffmanXinThera, San Diego, California, U.S.A.More by Robert L. HoffmanDOI: 10.1021/mc-2023-vol58.ch12Publication Date (Web):November 16, 2023Publication History Published online16 November 2023Request reuse permissions Copyright © 2023 MEDI, Inc. Published by American Chemical Society.2023 Medicinal Chemistry ReviewsChapter 12pp 283-311Medicinal Chemistry ReviewsVol. 58ISBN13: 9781734427462eISBN: 9781734427462Article Views97Altmetric-Citations-LEARN ABOUT THESE METRICSArticle Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated. Share Add toView InAdd Full Text with ReferenceAdd Description ExportRISCitationCitation and abstractCitation and referencesMore Options Share onFacebookTwitterWechatLinked InReddit Read OnlinePDF (1 MB) Get e-Alerts